Information Assured

Moderna, a pioneering biotech company, is at the forefront of an AI-driven workplace transformation, leveraging a deep partnership with OpenAI. This collaboration has led to the development of thousands of customized AI models, or GPTs, aimed at automating tasks previously performed by human employees, significantly impacting the company's operational structure. This strategic shift highlights a bold move towards integrating artificial intelligence into the core of pharmaceutical development and corporate functions. The partnership, initiated in 2023 with an internal employee chatbot, expanded significantly in April 2024, granting Moderna employees access to ChatGPT Enterprise. This platform empowers users to create specialized GPTs, like the successful Dose ID GPT, which efficiently evaluates optimal vaccine doses by analyzing vast amounts of data. These AI assistants are now deeply embedded across all business functions, from research and manufacturing to legal and commercial,...

In recent news, a real estate broker app has introduced "Ask Redfin," an AI-powered chatbot that assists users with property-related queries. Meanwhile, Google has unveiled its MediaPipe LLM Inference API, enabling developers to run AI models on devices with limited computing power. However, not all AI applications have been well-received, as demonstrated by the controversy surrounding Google's Gemini model, which generated offensive historical images. The music industry is also feeling the impact of AI, with songwriters expressing concerns about the technology's potential to replace human creativity. The legal landscape surrounding AI is becoming increasingly complex, with lawsuits being filed against tech companies for alleged copyright infringement and breaches of agreements. In one notable case, Microsoft invoked the analogy of VCRs in its motion to dismiss a lawsuit that The New York Times filed. Meanwhile, legal AI is gaining traction in Australia and could disr...